Accessibility Menu
Basel Medical Group logo

Basel Medical Group(NASDAQ) BMGL

Current Price$5.79
Market Cap$9.06MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-89%
5 YearN/A
1 Year-78%
1 Month-18%
Basel Medical Group last closing stock price
MetricPriceDate
Last closeUSD 5.792026-07-24
Basel Medical Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+10.08%USD 5.262026-07-17
1 month-17.64%USD 7.032026-06-24
3 month-22.18%USD 7.442026-04-24
Year to date-1.53%USD 5.882025-12-31
1 year-78.46%USD 26.882025-07-24
Since inception-89.13%USD 53.282025-02-25

Basel Medical Group Financials at a Glance

Market Cap

$9.06MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-$4.85

P/E Ratio

-1.19

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Price

$5.79

Volume

8,275

Open

$5.61

Previous Close

$5.79

Daily Range

$5.49 - $5.93

52-Week Range

$4.60 - $27.36

Estimated Earnings Date

N/A

BMGL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Basel Medical Group

Basel Medical Group Ltd is a healthcare company established in Singapore in 2023, focused on providing a comprehensive range of medical services. The company operates in various sectors, including specialist medical expertise, medical supplies, advanced technology solutions, and pharmaceuticals.

Products and Services
  • Specialist medical expertise across various healthcare fields
  • Medical supplies and equipment for healthcare facilities
  • Advanced medical technology solutions and pharmaceutical products
Growth Outlook
  • Recent quarterly revenue reached SGD 8.24 million, indicating strong demand
  • Significant increase in net income to SGD 268,443 in Q2 2025
  • Expansion plans in emerging markets to enhance service offerings
Financial Highlights
  • Trailing twelve months (TTM) revenue of SGD 8.24 million, showing growth potential
  • Current ratio of 1.88, indicating strong short-term financial health
  • Net income margin improved to 3.26% in the latest quarter
Basel Medical Group Ltd is positioned to capitalize on the growing demand for healthcare services. The recent revenue growth and improved net income reflect the company's operational efficiency and market potential. With a solid current ratio, the company demonstrates its ability to meet short-term obligations, which is crucial for sustaining growth. The focus on expanding into emerging markets further enhances its growth prospects, making it an intriguing option for investors interested in the healthcare sector.
AI Generated • Jul 21, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

70

CEO

Darren Chhoa, PhD

Website

baselmedical.com

Headquarters

Singapore, CE 188778, SG

BMGL Financials

Key Financial Metrics (TTM)

Gross Margin

-2.37%

Operating Margin

-31.66%

Net Income Margin

-67.66%

Return on Equity

-173.64%

Return on Capital

-26.36%

Return on Assets

-48.06%

Earnings Yield

-84.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.06MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.57M

Volume

8.28K

Avg. Volume

62.12K

Financials (TTM)

Gross Profit

-SGD 339.00K

Operating Income

-SGD 4.53M

EBITDA

-SGD 1.68M

Operating Cash Flow

-SGD 1.93M

Capital Expenditure

-SGD 643.31K

Free Cash Flow

-SGD 2.58M

Cash & ST Invst.

SGD 1.34M

Total Debt

SGD 9.87M

Basel Medical Group Performance Analysis

Basel Medical Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30SGD 7,837,981N/A
20232023-06-30SGD 7,108,579-9.3%
20242024-06-30SGD 7,453,0204.8%
20252025-06-30SGD 8,544,07914.6%
Basel Medical Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30N/A
Q22024-12-31N/A
Q42025-06-30N/A
Q22025-12-3136.1%
Basel Medical Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30SGD 1.07N/A
20232023-06-30SGD 0.96-10.2%
20242024-06-30SGD 1.1417.6%
20252025-06-30SGD -5.13N/A
Basel Medical Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30N/A
Q22024-12-31N/A
Q42025-06-30N/A
Q22025-12-31132.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

SGD 8.24M

N/A

Gross Profit

-SGD 983.32K

N/A

Gross Margin

-11.93%

N/A

Market Cap

$9.06MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$129.49K

N/A

Employees

70

N/A

Net Income

SGD 268.44K

N/A

EBITDA

-SGD 860.60K

N/A

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

SGD 1.34M

+42.3%

Total Debt

SGD 9.87M

+72.1%

Accounts Receivable

SGD 12.25M

-11.4%

Inventory

SGD 332.76K

+201.9%

Long Term Debt

SGD 6.04M

+141.1%

Short Term Debt

SGD 3.83M

+18.7%

Return on Assets

-48.06%

N/A

Return on Invested Capital

-35.92%

N/A

Free Cash Flow

-SGD 1.75M

N/A

Operating Cash Flow

-SGD 1.63M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INTSIntensity Therapeutics, Inc.
$4.45+0.45%
MODDModular Medical, Inc.
$2.51-17.43%
LDDDLongduoduo Company Limited
$0.51+0.00%
ITRMIterum Therapeutics plc
$0.03-10.98%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
FFord Motor Company
$14.37+0.02%

Questions About BMGL

What is the current price of Basel Medical Group?

Basel Medical Group is trading at $5.79 per share.

What is the 52-week range for Basel Medical Group?

Over the past 52 weeks, Basel Medical Group has traded between $4.60 and $27.36.

How much debt does Basel Medical Group have?

As of the most recent reporting period, Basel Medical Group reported total debt of SGD 3.99M.

How much cash does Basel Medical Group have on hand?

Basel Medical Group reported SGD 2.39M in cash and cash equivalents in its most recent financial results.

What is Basel Medical Group’s dividend yield?

Basel Medical Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services